BRIEF-Oragenics says U.S. FDA grants fast track designation for development of co’s AG013 for oral mucositis

Comments Off on BRIEF-Oragenics says U.S. FDA grants fast track designation for development of co’s AG013 for oral mucositis
* U.S. FDA grants fast track designation for the development of Oragenics' AG013 for oral mucositis

The post BRIEF-Oragenics says U.S. FDA grants fast track designation for development of co’s AG013 for oral mucositis appeared first on NASDAQ.

The post BRIEF-Oragenics says U.S. FDA grants fast track designation for development of co’s AG013 for oral mucositis appeared first on Forex news - Binary options.

The post BRIEF-Oragenics says U.S. FDA grants fast track designation for development of co’s AG013 for oral mucositis appeared first on Wallstreetsectorselector.info.

Reuters: Market News

Related Posts

Create Account



Log In Your Account